Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)
5.98
+0.09 (1.53%)
Aug 11, 2026, 3:04 PM CST
SHE:300639 Market Cap
SHE:300639 has a market cap or net worth of 3.75 billion as of August 11, 2026. Its market cap has decreased by -12.22% in one year.
Market Cap
3.75B
Enterprise Value
2.80B
Revenue
661.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.98
ChartMarket Cap Chart
Since April 12, 2017, SHE:300639's market cap has increased from 2.38B to 3.75B, an increase of 57.49%. That is a compound annual growth rate of 4.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 3.75B | 11.15% |
| Dec 31, 2025 | 3.38B | -10.48% |
| Dec 31, 2024 | 3.77B | -37.03% |
| Dec 29, 2023 | 5.99B | -18.63% |
| Dec 30, 2022 | 7.36B | -14.35% |
| Dec 31, 2021 | 8.59B | -2.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 6.95B |
| Beijing Strong Biotechnologies,Inc. | 6.87B |
| Shanghai Runda Medical Technology | 6.36B |
| Maccura Biotechnology Co.Ltd | 5.65B |
| Cowealth Medical China | 4.93B |
| Thalys Medical Technology Group | 3.85B |
| Shanghai Labway Clinical Laboratory | 3.77B |
| SMO ClinPlus CO.,LTD. | 3.73B |